Taking medication into Spain: what the rules actually say

The starting point is a single official page. The Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) publishes guidance on medicines intended for the treatment of travellers, which carried a last-updated date of 28 May 2026 when we read it. It is the most current official Spanish source on this question, and it is short.

On that page AEMPS states that the maximum quantity of medicine a traveller may carry must be appropriate to the prescribed treatment (in the original, "la cantidad máxima de medicamento que puede llevar un viajero deberá ser adecuada al tratamiento prescrito"), and not more than the amount needed for three months of treatment.

Two things follow from that wording. The first is that three months is a ceiling, not an entitlement: the quantity still has to look proportionate to the dose written on your prescription. Somebody carrying six months of a once-daily tablet is outside the stated limit even if the box is unopened. The second is that the test is applied per person and per treatment, so a family moving together is judged on each member's own prescriptions rather than on a household total.

If your circumstances genuinely need more than three months in one trip, that is a question to put to AEMPS before you fly rather than at the arrivals hall. Practical planning also matters more than most people expect for anything requiring refrigeration, so check the storage instructions on your own product labelling and ask your airline how it handles cold-chain items in the cabin.

The AEMPS traveller page states that presentation of the corresponding prescription or medical report may be required both on entry to and on exit from Spain. Note the direction of travel in that sentence. Most people prepare for arrival and forget that the same document can be asked for when they leave again, which matters if you are flying back for a visa appointment or a family event.

Because the requirement is stated as "receta o informe médico", a letter from your prescribing doctor does the same job as the prescription itself. A useful version of that letter is one page, on the practice's letterhead, and contains:

• your full name and date of birth, matching your passport exactly
• the prescriber's name, qualification, address and direct contact details
• each medicine by its international non-proprietary name (the generic active substance) as well as the brand you know it by
• the strength, the form, the daily dose and the total quantity you are carrying
• the condition being treated, in one plain sentence

Brand names diverge between the United States, the United Kingdom and Spain far more than active-substance names do, which is why the generic name is the field that actually travels. A Spanish translation is not something AEMPS requires on the page we read, but a bilingual letter costs nothing and removes a step for whoever is reading it. Keep the letter and the medicines in your hand luggage in their original labelled packaging, and keep a photograph of both on your phone.

Narcotics and psychotropics are carved out of the general rule. AEMPS states that a traveller entering Spain with these medicines must request a permit from the Área de Estupefacientes y Psicótropos of its Departamento de Inspección y Control de Medicamentos, and that a traveller leaving Spain requests a certificate authorising the transport instead. AEMPS sets out the detail on its narcotics and psychotropics page, which carried a last-updated date of 27 May 2026 when we read it.

On that page AEMPS states that the inbound request is made by email to its travellers address for controlled medicines, that the request must include the country of origin, the travel dates, the patient's details, the prescriber's details and the medicine's name, presentation and dosage, and that it must be accompanied by evidence of the need for the treatment and the prescribed daily doses. AEMPS states a maximum of three months of treatment for entry, with the permit valid for up to three months.

The categories caught by this are wider than people assume and include common stimulant treatments for ADHD, strong opioid painkillers and some sedatives. Whether your specific product is classified as a narcotic or psychotropic is a question for your prescriber and, if there is any doubt, for AEMPS directly. Do not decide it yourself from the packaging.

You can bring the medicines. You cannot generally walk into a Spanish pharmacy with a United States or United Kingdom prescription and have it dispensed.

Within the European Union there is a mechanism for this. The European Commission's Your Europe portal explains on its page about prescriptions abroad, last checked on 9 October 2025, that a prescription issued by a doctor in one EU country is recognised in the others, provided it carries the patient's full name and date of birth, the issue date, the prescriber's full name, professional qualification, direct contact details and work address including the country, and the medicine's common name rather than its brand name, together with format, quantity, strength and dosage.

That mechanism runs between EU countries. A prescription written in the United States or, since Brexit, in the United Kingdom sits outside it. The same Your Europe page also notes that dispensing is subject to the rules of the country where the prescription is presented, including time and dosage limits, so even an EU-issued prescription is read against Spanish pharmacy rules.

The practical consequence is simple and worth planning around: your imported supply is a bridge, and the thing you need on the other side of that bridge is a Spanish prescriber.

Once you have a Spanish prescription, what you pay depends on whether you are inside the public system and on your income. The Conselleria de Sanitat of the Generalitat Valenciana sets out the state pharmacy contribution on its page about the aportación farmacéutica estatal, which restates the national rule under Real Decreto-ley 16/2012 and Ley 11/2020. For working-age people it lists a contribution of 40% of the retail price where annual income is under €18,000, 50% from €18,000 up to €100,000, and 60% at €100,000 or more, with the income bracket assigned by the INSS from tax-agency data. Different bands and monthly caps apply to pensioners, and other autonomous communities restate the same state rule on their own pages, so check the one for where you live.

There is a gap that catches new arrivals. The Ministerio de Sanidad page on the convenio especial de prestación de asistencia sanitaria, the paid route into public healthcare for people without cover by another title, states that outpatient pharmacy is one of four items carrying a 100% patient contribution. It also states that applicants must evidence effective residence in Spain for a continuous minimum period of one year immediately before the application. So the route that gets many non-working new arrivals into the public system does not carry their medicines, and it is not open in the first year at all.

If the exact product you take is not marketed in Spain, AEMPS operates a separate foreign-medicines route. Its page on medicamentos extranjeros, published 12 June 2023, states that the Agency may exceptionally authorise access to medicines not authorised in Spain, that hospital requests come from the hospital pharmacy service, and that for outpatient dispensing the patient attends a "punto de contacto de medicación extranjera" with a medical report. Raise this with your Spanish doctor at the first appointment rather than when the last box runs out.

Almost everyone arriving on a Spanish long-stay visa has a period between landing and being registered in the public system, and for some routes that period is measured in months rather than weeks. Private health cover is what carries the medical risk across it, and for a family with an ongoing prescription it is worth reading the policy for two specific things rather than for the headline benefit.

The first is outpatient prescription medicines. Private medical policies are built mainly around consultations, diagnostics and hospital treatment, and the cost of drugs you collect from a pharmacy is often handled separately from the cost of the consultation that produced the prescription. Check whether outpatient pharmacy appears in the schedule of benefits at all, and if it does, what annual limit sits against it.

The second is pre-existing conditions. A condition you are already being treated for when the policy starts is treated differently from one that arises afterwards, and the medicines attached to it usually follow that treatment. This is a policy-wording question with a documented answer, so read the schedule of benefits and the exclusions before you rely on either point. Public entitlement, private cover and your imported supply are three separate things, and the planning risk is assuming one of them covers a gap left by another.